Market Place
Sourcing Support
J INTS BIO Launches AI-Supercomputing Alliance for Cancer Therapy
05 Nov 2024 //
PR NEWSWIRE
J Ints Bio Presents Interim Findings From Phase 1/2 Trial Of JIN-A02
24 Oct 2024 //
PR NEWSWIRE
J INTS BIO`s JIN-A02 Shows Tumor, Brain Metastasis Reductions In Phase 1
10 Jun 2024 //
PR NEWSWIRE
JINS BIO: Novel EGFR TKI JIN-A02 Shows Phase 1 Benefits
11 Apr 2024 //
PR NEWSWIRE
J INTS BIO Gives Presentation of Phase 1/2 study of `JIN-A02`
05 Dec 2023 //
PR NEWSWIRE
J INTS BIO, presentation of data of its Oral 4th Generation EGFR-TKI `JIN-A02`
15 Sep 2022 //
PRNEWSWIRE
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.